Trials within trials: confirmatory subgroup analyses in controlled clinical experiments.

Area of Science:

• Clinical Trials Methodology
• Biostatistics
• Medical Research Design

Background:

• Subgroup analyses are crucial in controlled clinical trials but often complicated by issues like lack of prospective specification and inadequate sample size.
• Interpreting subgroup findings can be challenging due to potential sampling errors and power limitations.

Purpose of the Study:

• To demonstrate the availability of clinical trial design tools for drawing confirmatory conclusions from subgroup evaluations.
• To present a methodology for evaluating intervention effects within specific, prospectively defined subgroup strata.

Main Methods:

• The proposed methodology focuses on evaluating intervention effects within a particular subgroup stratum.
• It emphasizes the prespecification of stratum-specific type I error rates.
• This approach is distinct from using a treatment-by-subgroup interaction term.

Main Results:

• The methodology allows for a "stand-alone" interpretation of subgroup strata at the trial's conclusion.
• Successful interpretation requires prespecification of stratum-specific type I error rates.
• Additional factors supporting interpretation include stratum-specific event rates, primary endpoints, endpoint precision, and efficacy.

Conclusions:

• Methodologists have access to clinical trial design tools that enable confirmatory subgroup analyses.
• Prospective specification of criteria, including error rates, is key to valid subgroup interpretation.
• This approach enhances the reliability and utility of subgroup evaluations in clinical trials.